Page 2 - Biondvax Adss News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biondvax adss. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biondvax Adss Today - Breaking & Trending Today

BiondVax Announces Pricing of $12.1 Million Follow-on Underwritten Offering of American Depositary Shares


Share this article
JERUSALEM, Jan. 29, 2021 /PRNewswire/  
BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and ultimately commercializing products for the prevention and treatment of infectious diseases and related illnesses, today announced the pricing of an underwritten public offering of 2,434,783 American Depositary Shares ( ADSs ), each representing forty ordinary shares, at a public offering price of $4.95 per ADS, for gross proceeds to the Company of approximately $12.1 million, before deducting underwriting discounts and other offering expenses.
BiondVax intends to use the net proceeds from the offering, together with its existing cash and cash equivalents, for general corporate purposes, which may include working capital, research and development activities, regulatory matters, capital investment or other related purposes. The Company may also use a portion of any net proceeds to in-license, inv ....

New York , United States , Israel General , Biondvax Adss , Joshuae Phillipson , Exchange Commission , Biondvax Pharmaceuticals Ltd , Syndicate Department , Aegis Capital Corp , Biondvax Pharmaceuticals , Depositary Shares , Vax Pharmaceuticals , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , இஸ்ரேல் ஜநரல் , பரிமாற்றம் தரகு , கூட்டமைப்பு துறை , ஆதரவு மூலதனம் கார்ப் , வ்யாக்ஸ் மருந்துகள் ,